ClinicalTrials.Veeva

Menu

Hyperpolarized 129Xe MRI Lung Health Cohort (XeLHC)

University of Kansas logo

University of Kansas

Status

Enrolling

Conditions

Healthy

Treatments

Drug: Hyperpolarized Xe129

Study type

Observational

Funder types

Other

Identifiers

NCT05766384
STUDY00160099

Details and patient eligibility

About

A subset of young adults participating in the American Lung Association (ALA) Lung Health Cohort (LHC) will be imaged using Hyperpolarized 129Xe MRI to assess lung structure and function. Images will be used to improve the understanding of lung health and early lung abnormalities that may lead to chronic lung disease.

Enrollment

260 estimated patients

Sex

All

Ages

25 to 35 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Is enrolled in the American Lung Association Lung Health Cohort Study.
  • Has completed CT imaging for the LHC study within 2 years of the scheduled Xe-MRI date.

Exclusion criteria

  • Pacemaker, internal defibrillator or other implanted electronic devices or any standard MRI contraindications (e.g., claustrophobia, > 140 cm shoulder circumference, dependent on weight distribution).
  • Is pregnant or breastfeeding
  • Oxygen saturation (SpO2) <88% on room air or with supplemental oxygen.

Trial contacts and locations

6

Loading...

Central trial contact

Cristal Monge

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems